Cargando…

Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival

AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulis, Leonie E., Klein, Alexandra M., Ghanem, Alexander, Geelen, Tessa, Coolen, Bram F., Breitbach, Martin, Zimmermann, Katrin, Nicolay, Klaas, Fleischmann, Bernd K., Roell, Wilhelm, Strijkers, Gustav J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621863/
https://www.ncbi.nlm.nih.gov/pubmed/23585908
http://dx.doi.org/10.1371/journal.pone.0061510
_version_ 1782265775733604352
author Paulis, Leonie E.
Klein, Alexandra M.
Ghanem, Alexander
Geelen, Tessa
Coolen, Bram F.
Breitbach, Martin
Zimmermann, Katrin
Nicolay, Klaas
Fleischmann, Bernd K.
Roell, Wilhelm
Strijkers, Gustav J.
author_facet Paulis, Leonie E.
Klein, Alexandra M.
Ghanem, Alexander
Geelen, Tessa
Coolen, Bram F.
Breitbach, Martin
Zimmermann, Katrin
Nicolay, Klaas
Fleischmann, Bernd K.
Roell, Wilhelm
Strijkers, Gustav J.
author_sort Paulis, Leonie E.
collection PubMed
description AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model. METHODS AND RESULTS: Myocardial infarction (MI) was induced in mice (n = 75), followed by the intramyocardial injection of 1−2×10(5) luciferase- and GFP-expressing embryonic cardiomyocytes (eCMs), skeletal myoblasts (SMs), mesenchymal stem cells (MSCs) or medium into the infarct. Non-treated healthy mice (n = 6) served as controls. Bioluminescence and fluorescence imaging confirmed the engraftment and survival of the cells up to seven weeks postoperatively. After two weeks MRI was performed, which showed that infarct volume was significantly decreased by eCMs only (14.8±2.2% MI+eCM vs. 26.7±1.6% MI). Left ventricular dilation was significantly decreased by transplantation of any cell type, but most efficiently by eCMs. Moreover, eCM treatment increased the ejection fraction and cardiac output significantly to 33.4±2.2% and 22.3±1.2 ml/min. In addition, this cell type exclusively and significantly increased the end-systolic wall thickness in the infarct center and borders and raised the wall thickening in the infarct borders. Repetitive echocardiography examinations at later time points confirmed that these beneficial effects were accompanied by better survival rates. CONCLUSION: Cellular cardiomyoplasty employing contractile and electrically coupling embryonic cardiomyocytes (eCMs) into ischemic myocardium provoked significantly smaller infarcts with less adverse remodeling and improved cardiac function and long-term survival compared to transplantation of somatic cells (SMs and MSCs), thereby proving that a cardiomyocyte phenotype is important to restore myocardial function.
format Online
Article
Text
id pubmed-3621863
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36218632013-04-12 Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival Paulis, Leonie E. Klein, Alexandra M. Ghanem, Alexander Geelen, Tessa Coolen, Bram F. Breitbach, Martin Zimmermann, Katrin Nicolay, Klaas Fleischmann, Bernd K. Roell, Wilhelm Strijkers, Gustav J. PLoS One Research Article AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic progenitor cells upon myocardial injury. We have therefore investigated the functional short- and long-term consequences after intramyocardial transplantation of these cell types in a murine lesion model. METHODS AND RESULTS: Myocardial infarction (MI) was induced in mice (n = 75), followed by the intramyocardial injection of 1−2×10(5) luciferase- and GFP-expressing embryonic cardiomyocytes (eCMs), skeletal myoblasts (SMs), mesenchymal stem cells (MSCs) or medium into the infarct. Non-treated healthy mice (n = 6) served as controls. Bioluminescence and fluorescence imaging confirmed the engraftment and survival of the cells up to seven weeks postoperatively. After two weeks MRI was performed, which showed that infarct volume was significantly decreased by eCMs only (14.8±2.2% MI+eCM vs. 26.7±1.6% MI). Left ventricular dilation was significantly decreased by transplantation of any cell type, but most efficiently by eCMs. Moreover, eCM treatment increased the ejection fraction and cardiac output significantly to 33.4±2.2% and 22.3±1.2 ml/min. In addition, this cell type exclusively and significantly increased the end-systolic wall thickness in the infarct center and borders and raised the wall thickening in the infarct borders. Repetitive echocardiography examinations at later time points confirmed that these beneficial effects were accompanied by better survival rates. CONCLUSION: Cellular cardiomyoplasty employing contractile and electrically coupling embryonic cardiomyocytes (eCMs) into ischemic myocardium provoked significantly smaller infarcts with less adverse remodeling and improved cardiac function and long-term survival compared to transplantation of somatic cells (SMs and MSCs), thereby proving that a cardiomyocyte phenotype is important to restore myocardial function. Public Library of Science 2013-04-09 /pmc/articles/PMC3621863/ /pubmed/23585908 http://dx.doi.org/10.1371/journal.pone.0061510 Text en © 2013 Paulis et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Paulis, Leonie E.
Klein, Alexandra M.
Ghanem, Alexander
Geelen, Tessa
Coolen, Bram F.
Breitbach, Martin
Zimmermann, Katrin
Nicolay, Klaas
Fleischmann, Bernd K.
Roell, Wilhelm
Strijkers, Gustav J.
Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
title Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
title_full Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
title_fullStr Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
title_full_unstemmed Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
title_short Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-Term Survival
title_sort embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621863/
https://www.ncbi.nlm.nih.gov/pubmed/23585908
http://dx.doi.org/10.1371/journal.pone.0061510
work_keys_str_mv AT paulisleoniee embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT kleinalexandram embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT ghanemalexander embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT geelentessa embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT coolenbramf embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT breitbachmartin embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT zimmermannkatrin embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT nicolayklaas embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT fleischmannberndk embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT roellwilhelm embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival
AT strijkersgustavj embryoniccardiomyocytebutnotautologousstemcelltransplantationrestrictsinfarctexpansionenhancesventricularfunctionandimproveslongtermsurvival